secwatch.observer — SEC 8-K summary
======================================

Issuer:     Pyxis Oncology, Inc. (PYXS)
CIK:        0001782223
Form:       8-K
Filed at:   2024-03-13T23:59:59+00:00
Accession:  0000950170-24-030817
Event type: leadership
Sentiment:  neutral
Materiality: 0.35
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Pyxis Oncology appoints Santhosh Palani, Ph.D., CFA to board; grant of 69,760 options
--------------------------------------------------------------------------------

- Santhosh Palani appointed to Pyxis Oncology board effective March 12, 2024.
- Dr. Palani brings strategic and investment experience from PFM Health Sciences, NEA, and Cowen.
- Received stock options for 69,760 shares at $5.70 exercise price, vesting over 3 years.
- No committee assignments yet; independent director under Nasdaq standards.
- Press release issued March 13, 2024 announcing the appointment.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1782223/000095017024030817/0000950170-24-030817-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1782223/000095017024030817/pyxs-20240312.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-030817

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer